Krop IE - Search Results

1

PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers.

Wang Q, Liu P, Spangle JM, Von T, Roberts TM, Lin NU, Krop IE, Winer EP, Zhao JJ. Wang Q, et al. Among authors: krop ie. Oncogene. 2016 Jul 7;35(27):3607-12. doi: 10.1038/onc.2015.406. Epub 2015 Oct 26. Oncogene. 2016. PMID: 26500061 Free PMC article.

2

Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression).

Seth P, Krop I, Porter D, Polyak K. Seth P, et al. Oncogene. 2002 Jan 24;21(5):836-43. doi: 10.1038/sj.onc.1205113. Oncogene. 2002. PMID: 11850811

3

Ovarian suppression for breast cancer: an effective treatment in search of a home.

Krop IE, Winer EP. Krop IE, et al. J Clin Oncol. 2005 Sep 1;23(25):5869-72. doi: 10.1200/JCO.2005.06.002. Epub 2005 Aug 8. J Clin Oncol. 2005. PMID: 16087947 No abstract available.

4

Ten years of HER2-directed therapy: still questions after all these years.

Krop IE, Winer EP. Krop IE, et al. Breast Cancer Res Treat. 2009 Jan;113(2):207-9. doi: 10.1007/s10549-008-0041-2. Epub 2008 May 8. Breast Cancer Res Treat. 2009. PMID: 18463974 No abstract available.

5

Mechanisms of trastuzumab resistance in breast cancer.

Tolaney SM, Krop IE. Tolaney SM, et al. Among authors: krop ie. Anticancer Agents Med Chem. 2009 Mar;9(3):348-55. doi: 10.2174/1871520610909030348. Anticancer Agents Med Chem. 2009. PMID: 19275526 Review.

6

GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays.

Li A, Liu Z, Lezon-Geyda K, Sarkar S, Lannin D, Schulz V, Krop I, Winer E, Harris L, Tuck D. Li A, et al. Nucleic Acids Res. 2011 Jul;39(12):4928-41. doi: 10.1093/nar/gkr014. Epub 2011 Mar 11. Nucleic Acids Res. 2011. PMID: 21398628 Free PMC article.

7

Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer.

Olson EM, Lin NU, DiPiro PJ, Najita JS, Krop IE, Winer EP, Burstein HJ. Olson EM, et al. Among authors: krop ie. Ann Oncol. 2012 Jan;23(1):93-97. doi: 10.1093/annonc/mdr061. Epub 2011 Apr 29. Ann Oncol. 2012. PMID: 21531783 Free PMC article.

8

A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases.

Freedman RA, Bullitt E, Sun L, Gelman R, Harris G, Ligibel JA, Krop IE, Partridge AH, Eisenberg E, Winer EP, Lin NU. Freedman RA, et al. Among authors: krop ie. Clin Breast Cancer. 2011 Dec;11(6):376-83. doi: 10.1016/j.clbc.2011.03.024. Epub 2011 Jun 22. Clin Breast Cancer. 2011. PMID: 21697017 Free PMC article. Clinical Trial.

9

Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.

Morrow PK, Wulf GM, Ensor J, Booser DJ, Moore JA, Flores PR, Xiong Y, Zhang S, Krop IE, Winer EP, Kindelberger DW, Coviello J, Sahin AA, Nuñez R, Hortobagyi GN, Yu D, Esteva FJ. Morrow PK, et al. Among authors: krop ie. J Clin Oncol. 2011 Aug 10;29(23):3126-32. doi: 10.1200/JCO.2010.32.2321. Epub 2011 Jul 5. J Clin Oncol. 2011. PMID: 21730275 Free PMC article. Clinical Trial.

10

The ethical use of mandatory research biopsies.

Olson EM, Lin NU, Krop IE, Winer EP. Olson EM, et al. Among authors: krop ie. Nat Rev Clin Oncol. 2011 Aug 2;8(10):620-5. doi: 10.1038/nrclinonc.2011.114. Nat Rev Clin Oncol. 2011. PMID: 21808265 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page